Riskpilot← Back to searchSign inGet full accessNordiskVision AB
ABActiveOrg 5593814261Trädgårdssångarvägen 19General medical practice activities · NACE 8621Est. 20221 employees
Revenue 2025
SEK 1,1M
EBITDA margin
44.6%
Equity ratio
79.2%
Financial strength
Net profit 2025
SEK 376K
1 employees
| Revenue | SEK 1,1M | — |
| EBITDA | SEK 474K | — |
| Net profit | SEK 376K | — |
| Total assets | SEK 506K | +1922% |
| Equity | SEK 401K | +1502% |
| Employees | 1 | — |
Legal name
NordiskVision AB
Org number
5593814261
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 maj 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget ska bedriva oftalmologisk verksamhet, där specialistvård inom ögonsjukdomar och synproblem erbjuds. Företaget ska även bedriva undervisning, handledning och samtalscoachning, inom den privata och offentliga sektorn.
Address
Trädgårdssångarvägen 19
Email
nordiskvision.info@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 1 062 |
| Staff expenses | — | — | — | −450 |
| EBITDA | — | — | — | 474 |
| Depreciation & amort. | −0 | −0 | −0 | — |
| EBIT | 0 | 0 | 0 | 474 |
| Net financials | — | — | — | 0 |
| Profit before tax | 0 | 0 | 0 | 474 |
| Tax | −0 | −0 | −0 | −98 |
| Net profit | 0 | 0 | 0 | 376 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 25 | 25 | 25 | 506 |
| Equity | 25 | 25 | 25 | 401 |
| Long-term debt | 0 | 0 | 0 | — |
| Short-term debt | 0 | 0 | 0 | 105 |
| Total debt | — | — | — | 105 |
EBITDA margin
44.6%
This company
15.8%
Market median
+182% vs market
20222025
Equity ratio
79.2%
This company
38.2%
Market median
+107% vs market
20222025
Return on equity
93.8%
This company
18.4%
Market median
+410% vs market
20222025
Net profit margin
35.4%
This company
8.1%
Market median
+337% vs market
20222025
Asset turnover
2.10×
This company
1.12×
Market median
+87% vs market
20222025
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-05-01 – 2022-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PL Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NordiskVision AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pedro Luis Garcia Hermosa | Deputy Chief Executive Officer | 0 companies |
| Marie Karin Anna Thuland | Chairman | 0 companies |
| Jan Edvin Söderman | Deputy Board Member | 0 companies |